Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivation.

Takanori SuzukiTakako InoueKentaro MatsuuraShigeru KusumotoShinya HagiwaraShintaro OgawaShintaro YagiAtsushi KanekoKei FujiwaraTakehisa WatanabeKatsumi AoyagiYukitomo UrataAkihiro TamoriHiromi KataokaYasuhito Tanaka

Published in: Journal of gastroenterology (2022)

The iTACT-HBcrAg assay is useful for monitoring HBV reactivation to determine the initiation of treatment with nucleos(t)ide analogues.

Keyphrases

hepatitis b virus
liver failure
combination therapy
molecular docking